The contribution of in vivo manipulation of gene expression to the understanding of the function of glypicans
- PMID: 12975611
- DOI: 10.1023/A:1025312819804
The contribution of in vivo manipulation of gene expression to the understanding of the function of glypicans
Abstract
The name glypican identifies a family of heparan sulfate proteoglycans that are linked to the cell surface by a glycosylphosphatidylinositol anchor. Members of this family have been identified in Drosophila, zebrafish, and mammals. The interest in the study of glypicans has increased in the last few years as a result of the discovery that the glypican-3 gene (GPC-3) is mutated in an overgrowth and dysmorphic syndrome. Despite the increased interest, our knowledge about the function of glypicans is still limited, since the molecular basis for the role of glypican-3 in the regulation of body size remains unknown. The in vivo manipulation of glypican expression in lower organisms, however, has demonstrated that these proteoglycans can modulate cellular responses to Wnts and bone morphogenetic factors. Future studies should investigate whether the phenotype of GPC-3-deficient individuals is also due to altered modulation of cellular responses to these factors.
Similar articles
-
Glypicans in growth control and cancer.Glycobiology. 2001 Mar;11(3):19R-23R. doi: 10.1093/glycob/11.3.19r. Glycobiology. 2001. PMID: 11320054 Review.
-
The role of glypicans in mammalian development.Biochim Biophys Acta. 2002 Dec 19;1573(3):241-6. doi: 10.1016/s0304-4165(02)00390-2. Biochim Biophys Acta. 2002. PMID: 12417406 Review.
-
Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition.Mol Genet Metab. 2001 Apr;72(4):279-86. doi: 10.1006/mgme.2001.3150. Mol Genet Metab. 2001. PMID: 11286501 Review.
-
glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development.Dev Biol. 2000 Sep 1;225(1):179-87. doi: 10.1006/dbio.2000.9831. Dev Biol. 2000. PMID: 10964473
-
Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans.J Biol Chem. 1999 Sep 17;274(38):26968-77. doi: 10.1074/jbc.274.38.26968. J Biol Chem. 1999. PMID: 10480909
Cited by
-
Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients.Mol Biol Rep. 2012 Jan;39(1):351-7. doi: 10.1007/s11033-011-0745-y. Epub 2011 Jun 8. Mol Biol Rep. 2012. PMID: 21655958
-
Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature.Jpn J Radiol. 2013 Jul;31(7):480-90. doi: 10.1007/s11604-013-0224-6. Epub 2013 Jun 16. Jpn J Radiol. 2013. PMID: 23771695
-
Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3.Clin Case Rep. 2015 Jun;3(6):444-7. doi: 10.1002/ccr3.279. Epub 2015 Apr 17. Clin Case Rep. 2015. PMID: 26185646 Free PMC article.
-
Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies.J Hepatocell Carcinoma. 2017 Jul 11;4:93-103. doi: 10.2147/JHC.S106529. eCollection 2017. J Hepatocell Carcinoma. 2017. PMID: 28744453 Free PMC article. Review.
-
Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma.Cancer Sci. 2009 Aug;100(8):1403-7. doi: 10.1111/j.1349-7006.2009.01206.x. Epub 2009 May 4. Cancer Sci. 2009. PMID: 19496787 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases